10:00 AM EDT, 08/09/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) , which is advancing therapeutic options for sepsis and septic shock, announced on Friday a higher second-quarter loss due to increased operating expenses.

For the three-months ended June 30, Spectral posted a $4.4 million loss, or $0.02 per share, compared to $4.2 million, or $0.02 per share, in the same quarter last year.

Revenue on the quarter rose 54% to $471,000 from $306,000.

Price: 0.62, Change: +0.02, Percent Change: +3.33